Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment
Jeffrey J. Jackson, John M. Ketcham, Ashkaan Younai, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6190-6213
Closed Access | Times Cited: 24

Showing 24 citing articles:

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li, Ping Jiang, Shuhua Wei, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 641
Immunotherapy of Cancer by Targeting Regulatory T cells
Bo-Jin Chen, Jingwen Zhao, Dahong Zhang, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108469-108469
Open Access | Times Cited: 76
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Justine Cinier, Margaux Hubert, Laurie Besson, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1850-1850
Open Access | Times Cited: 74
Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5647-5647
Open Access | Times Cited: 70
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
Bayley McRitchie, Billur Akkaya
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
CCL22 Signaling in the Tumor Environment
Natascha Röhrle, Maximilian M. L. Knott, David Anz
Advances in experimental medicine and biology (2020), pp. 79-96
Closed Access | Times Cited: 43
Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma
Zihang Ling, Wei Li, Jiaqi Hu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 25
SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma
Baozhen Wang, Yichen Yin, Anqi Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors
Omar Robles, Jeffrey J. Jackson, Lisa A. Marshall, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 15, pp. 8584-8607
Closed Access | Times Cited: 24
Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features
Mingyong Liu, Dmytro Starenki, Christopher D. Scharer, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 641-655
Open Access | Times Cited: 9
Clinical Aspects and Significance of β-Chemokines, γ-Chemokines, and δ-Chemokines in Molecular Cancer Processes in Acute Myeloid Leukemia (AML) and Myelodysplastic Neoplasms (MDS)
Jan Korbecki, Mateusz Bosiacki, Piotr Stasiak, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3246-3246
Open Access | Times Cited: 1
Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity
Yichao Lu, Xu Liu, Jian You
Nano Today (2023) Vol. 54, pp. 102129-102129
Closed Access | Times Cited: 3
Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3+CCR4+CD8+ T Cells That Mediate Rapid Hepatocyte Allograft Rejection
Jason M. Zimmerer, Bryce A. Ringwald, Sachi Chaudhari, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 12, pp. 3107-3121
Open Access | Times Cited: 7
Small Molecular Immune Modulators as Anticancer Agents
Yongxin Han, Li Zhu, Wei Wu, et al.
Advances in experimental medicine and biology (2020), pp. 547-618
Closed Access | Times Cited: 7
Identification of immune-related genes in the prognosis of head and neck cancer using a novel prognostic signature model
Aoshuang Chang, Yan Wang, Xiaopeng Guo, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2023) Vol. 136, Iss. 4, pp. 478-489
Closed Access | Times Cited: 2
Small molecule inhibitors targeting regulatory T cells for cancer treatment
Nuria García‐Díaz, Wei Qian, Kjetil Taskén
European Journal of Immunology (2023) Vol. 54, Iss. 2
Open Access | Times Cited: 2
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA
Jihyun Kim, Jocelyn Pena, Hannah P. McQueen, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 1, pp. 28-42
Closed Access | Times Cited: 2
Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors
Man Liu, Hang Yu, Luohai Chen, et al.
Neuroendocrinology (2023) Vol. 114, Iss. 9, pp. 827-839
Open Access | Times Cited: 2
Enzyme-responsive mannose-grafted magnetic nanoparticles for breast and liver cancer therapy and tumor-associated macrophage immunomodulation
Gholam Hossein Darya, O Zare, Hamid Reza Karbalaei‐Heidari, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 663-677
Closed Access
Pseudopeptides with aldehyde or vinylsulfone warheads: Synthesis and antiproteasomal activity
Radek Jorda, Veronika Molitorová, Eliška Pilařová, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105228-105228
Closed Access | Times Cited: 3
Six-membered ring systems: diazines and benzo derivatives
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2021), pp. 431-466
Closed Access | Times Cited: 1
Synthesis of a CCR4 Antagonist
Philip Kocieński
Synfacts (2019) Vol. 15, Iss. 10, pp. 1103-1103
Closed Access
Interferon regulatory factor 3 upregulates the Treg recruitment factor CCL22 in response to double-stranded DNA in cancer cells
Jihyun Kim, Jocelyn Pena, Hannah P. McQueen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA
Jihyun Kim, Jocelyn Pena, Hannah P. McQueen, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top